(429 days)
Not Found
No
The description focuses on the physical design and function of bipolar electrodes for electrosurgery, with no mention of AI or ML capabilities.
Yes
The device is used for "coagulation of soft tissue during open or minimally invasive surgical procedures," which directly describes a therapeutic action.
No
The device is indicated for the "coagulation of soft tissue during open or minimally invasive surgical procedures," which is a therapeutic function, not a diagnostic one.
No
The device description clearly details physical components like electrodes, handles, shafts, and plug connections, indicating it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "coagulation of soft tissue during open or minimally invasive surgical procedures." This is a therapeutic procedure performed directly on a patient's tissue, not a diagnostic test performed on a sample taken from a patient.
- Device Description: The description details a surgical instrument used for electrosurgery, not a device for analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing samples (blood, urine, tissue, etc.), detecting biomarkers, or providing diagnostic information.
IVD devices are used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device's function is to surgically alter tissue, which is a therapeutic action.
N/A
Intended Use / Indications for Use
The maxmorespine Bipolar Electrodes are indicated for the coagulation of soft tissue during open or minimally invasive surgical procedures when used in conjunctible radio frequency generator. The maxmorespine Bipolar Electrodes have not been shown to be effective for tubal coagulation for sterilization for sterilization procedures and should not be used for these procedures.
Product codes
GEI
Device Description
maxmorespine Bipolar Electrodes are designed with a rounded distal end, an ergonomic handle in various designs and a flat plug connection. The electrodes are sold as one-piece electrodes (1001-BE 003) or consist of a three-piece construction (shaft, electrode and handle). The one-piece electrode and electrodes (1001-BE 002 and 1001-BE 004) are sold as sterile, single-use devices. The handles and shafts (1001-BE 001/H, 1001-BE 001/s and 1001-BE 004/S) are intended for reuse.
The maxmorespine Bipolar Electrodes can be connected to HF electrosurgical generators that have the permissible Vp voltage via a flat plug using the standard bipolar connection cables.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
soft tissue
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Data:
Biocompatibility Testing: The patient contact materials were evaluated against the international standard ISO 10993-1 and the FDA Guidance Document "Use of International Standard ISO 10993-1". Tests considered were Cytotoxicity, Sensitization, Irritation, Pyrogenicity.
Electrical Safety: Testing was conducted consistent with IEC 60601-1:2012 and IEC 60601-2-2:2017.
Sterilization: Successful sterilization validation testing was conducted according to ISO 11135, achieving a SAL of 10-6.
Packaging Validation: Testing was successfully conducted according to ISO 11607-1.
Software Verification and Validation: The maxmorespine Bipolar Electrodes do not contain software.
Tissue Performance Testing: The performance was evaluated with tissues of various density (muscle, kidney, and liver) and shown to be substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
Hoogland Spine Products, GmbH Mr. Kenneth K. Kleinhenz, MBA Principal OSR Consulting 10807 Dakota Ranch Rd. Santee, California A92071
Re: K211173
Trade/Device Name: maxmorespine Bipolar Electrodes Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation devices and accessories Regulatory Class: Class II Product Code: GEI Dated: April 22, 2022 Received: April 22, 2022
Dear Mr. Kleinhenz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for
Long Chen, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K211173
Device Name maxmorespine® Bipolar Electrodes
Indications for Use (Describe)
The maxmorespine Bipolar Electrodes are indicated for the coagulation of soft tissue during open or minimally invasive surgical procedures when used in conjunctible radio frequency generator. The maxmorespine Bipolar Electrodes have not been shown to be effective for tubal coagulation for sterilization for sterilization procedures and should not be used for these procedures.
Type of Use (Select one or both, as applicable)
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Date Prepared: 22 June 2022
SUBMITTER I.
Manufacturer Name:
Hoogland Spine Products, GmbH Feringastrasse 4 D-85774 Unterfoering Munich, Germany +49 34954 247 489 telephone
Mfg. Establishment Registration Number: 3006561161
Official Contact:
Mr. Kenneth K. Kleinhenz, MBA Principal OSR Consulting 10807 Dakota Ranch Rd. Santee, CA92071 Telephone (619) 244-9573 Kleinhenz64@gmail.com
II. DEVICE
| Name of Device: | maxmorespine Bipolar Electrodes |
|---|---|
| Common or Usual Name: | Electrosurgical Cutting and Coagulation Devices and Accessories |
| Classification Name: | Electrosurgical Cutting and Coagulation Devices and |
| Accessories (21 CFR 878.4400) | |
| Regulatory Class: | II |
| Product Code: | GEI |
III. PREDICATE DEVICE
joimax Electrosurgical Instruments, K161378
IV. DEVICE DESCRIPTION
Design Characteristics
maxmorespine Bipolar Electrodes are designed with a rounded distal end, an ergonomic handle in various designs and a flat plug connection. The electrodes are sold as one-piece electrodes (1001-BE 003) or consist of a three-piece construction (shaft, electrode and handle). The one-piece electrode and electrodes (1001-BE 002 and 1001-BE 004) are sold as sterile, single-use devices. The handles and shafts (1001-BE 001/H, 1001-BE 001/s and 1001-BE 004/S) are intended for reuse.
4
The maxmorespine Bipolar Electrodes can be connected to HF electrosurgical generators that have the permissible Vp voltage via a flat plug using the standard bipolar connection cables. The maxmorespine Bipolar Electrodes consist of the following electrodes and accessories:
| 1001-BE 001/H | Bipolar Forceps Handle for Flexible Electrodes with Flat-Plug |
|---|---|
| 1001-BE 001/S | Shaft for Bipolar Forceps Handle for Flexible Electrodes, Long |
| 1001-BE 002 | Bipolar Coagulation Electrode, Flexible, Long |
| 1001-BE 003 | Bipolar Coagulation Electrode |
| 1001-BE 004/S | Shaft for Bipolar Forceps Handle for Flexible Electrodes, Short |
| 1001-BE 004 | Bipolar Coagulation Electrode, Flexible, Short |
The following products are provided sterile. They are sterilized by ethylene oxide sterilization: 1001-BE 002 Bipolar Coagulation Electrode, Flexible, Long Bipolar Coagulation Electrode 1001-BE 003
1001-BE 004 Bipolar Coagulation Electrode, Flexible, Short
The following products are reusable:
| 1001-BE 001/H | Bipolar Forceps Handle for Flexible Electrodes with Flat-Plug |
|---|---|
| 1001-BE 001/S | Shaft for Bipolar Forceps Handle for Flexible Electrodes, Long |
| 1001-BE 004/S | Shaft for Bipolar Forceps Handle for Flexible Electrodes, Short |
V. INDICATIONS FOR USE
The maxmorespine Bipolar Electrodes are indicated for the coagulation of soft tissue during open or minimally invasive surgical procedures when used in conjunction with a compatible radio frequency generator. The maxmorespine Bipolar Electrodes have not been shown to be effective for tubal sterilization or tubal coagulation for sterilization procedures and should not be used for these procedures.
5
VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE
The maxmorespine Bipolar Electrodes shares indications for use and design principles with the predicate device: joimax Electrosurgical Instruments predicate device (K161378); a Class II medical device that was cleared for marketing in the United States under K161378. The design principles of the maxmorespine Bipolar Electrodes device and the joimax Electrosurgical Instruments predicate device (K161378) are substantially equivalent, consisting of sterile, single use, detachable, flexible electrodes of various lengths, reusable stainless steel guide cannula / shaft that facilitates the flexible electrode to pass through the shaft of the cannula, and a reusable handle that attaches to the guide cannulas on one end and the generator on the opposite end. The subject device and the predicate device also share the same design feature a detachable electrode and cannula / shaft that mount to the handle; both designs allowing for the use of various electrode lengths depending on the physician's needs / surgical approach. Furthermore, the maxmorespine Bipolar Electrodes device and the joimax Electrosurgical Instruments (K161378) predicate device share substantially equivalent design principals of providing a single use, sterile, 'pencil' design in which the electrode is permanently mounted on a fixed male fitting that plugs into the handle; which is connected to a generator that provides power to the electrode.
| Subject Device | Predicate Device | |
|---|---|---|
| maxmorespine Bipolar Electrodes | joimax Electrosurgical Instruments | |
| (K161378) | ||
| Indications | ||
| for Use | The maxmorespine Bipolar Electrodes | |
| are indicated for the coagulation of | ||
| soft tissue during open or minimally | ||
| invasive surgical procedures when | ||
| used in conjunction with a compatible | ||
| radio frequency generator. The | ||
| maxmorespine Bipolar Electrodes have | ||
| not been shown to be effective for | ||
| tubal sterilization or tubal coagulation | ||
| for sterilization procedures and should | ||
| not be used for these procedures. | The joimax Electrosurgical Instruments are | |
| indicated for the coagulation of soft tissue during | ||
| open or minimally invasive surgical procedures | ||
| when used in conjunction with a compatible radio | ||
| frequency generator. The joimax Electrosurgical | ||
| Instruments have not been shown to be effective | ||
| for tubal sterilization or tubal coagulation for | ||
| sterilization procedures and should not be used | ||
| for these procedures. | ||
| Mode of | ||
| Operation | Bipolar | Bipolar |
| Mechanics of | ||
| Action | Coagulation | Coagulation |
The maxmorespine Bipolar Electrodes are substantially equivalent to the joimax Electrosurgical Instruments predicate device (K161378) in the following respects:
6
| Subject Device | Predicate Device | |
|---|---|---|
| maxmorespine Bipolar Electrodes | joimax Electrosurgical Instruments | |
| (K161378) | ||
| Activation | ||
| Method | Footswitch | Footswitch |
| Trade Names | - Bipolar Forceps Handle |
- Shaft for Bipolar Forceps Handle
- Bipolar Coagulation Electrode, Flexible | - Vaporflex Handle
- Vaporflex Shaft
- Vaporflex Probe, Bipolar, Ball Tip |
| Design | Image: maxmorespine Bipolar Electrodes design | Image: joimax Electrosurgical Instruments design |
| Reusable
Handle and
Shaft | Yes | Yes |
| Sterile,
Single-Use
Electrode | Yes | Yes |
| Flexible Tip | Yes | Yes |
| Shaft
Diameter | 2.3mm | 2.75mm |
| Shaft Lengths | 272mm / 408.8mm | 250mm / 275mm/ 320mm |
| Electrode
Lengths | 363.2mm / 500mm | 250mm / 275mm / 320mm |
| Maximum
output
voltage | 250 Vp | 1200 Vp |
| Product Code | GEI | GEI |
| Regulation
Number | 878.4400 | 878.4400 |
7
| Subject Device | Predicate Device | |
|---|---|---|
| maxmorespine Bipolar Electrodes | joimax Electrosurgical Instruments | |
| (K161378) | ||
| Trade Names | - Bipolar Coagulation Electrode | - Legato Probe, Bipolar, Ball Tip 270 |
- Legato Handpiece bipolar |
| Image | Image: maxmorespine Bipolar Electrodes | Image: joimax Electrosurgical Instruments |
| Sterile,
Single-Use
Electrode | Yes | Yes |
| Sterilization
Method | Ethylene oxide (EO) | Ethylene oxide (EO) |
| Flexible Tip | Yes | Yes |
| Shaft
Diameter | 1.35mm | 2.0mm |
| Shaft Length | 377mm | 270mm |
| Product
Code | GEI | GEI |
| Regulation
Number | 878.4400 | 878.4400 |
VII. PERFORMANCE DATA
Non-Clinical Data
Biocompatibility Testing
The patient contact materials were evaluated against the international standard ISO 10993-1 (Biological Evaluation of Medical Devices) and the FDA Guidance Document entitled, "Use of International Standard ISO 10993-1, "Biological Evaluation of Medical Devices -Part 1: Evaluation and Testing within a Risk Management Process". The following biocompatibility tests were considered:
- Cytotoxicity Sensitization Irritation Pyrogenicity
8
Electrical Safety
Electrical safety and EMC testing were conducted on the maxmorespine Bipolar Electrodes device, consistent with the appropriate sections of the following electrical standards: IEC 60601-1:2012 Medical electrical equipment - Part 1-General requirements for basic safety and essential performance, IEC 60601-2-2:2017. Medical electrical equipment - Part 2-2: Particular requirements for the basic safety and essential performance of high frequency surgical equipment and high frequency surgical accessories.
Sterilization
Successful sterilization validation testing was conducted according to the ISO 11135. Tests were performed on the residues of ethylene oxide (EO). The validation target of a sterilization acceptance level (SAL) of 10-6 was achieved.
Packaging Validation
Testing of the primary packaging for the maxmorespine Bipolar Electrodes was successfully conducted according to ISO 11607-1.
Software Verification and Validation
The maxmorespine Bipolar Electrodes do not contain software.
Tissue Performance Testing
The performance of the maxmorespine Bipolar Electrodes have been evaluated with tissues of various density (muscle, kidney, and liver) and have been shown to be substantially equivalent to the predicate device.
VII. CONCLUSIONS
Performance testing on various tissue types (muscle, kidney, liver) has demonstrated that the performance of the maxmorespine Bipolar Electrodes are substantial equivalent to the predicate device (K161378). The nonclinical testing demonstrate that the subject device is safe and substantially equivalent to the predicate device. The performance testing and nonclinical testing demonstrate that the maxmorespine Bipolar Electrosurgical Instruments are substantially equivalent to the predicate device and do not raise new questions regarding the safety and effectiveness as compared to the predicate device (K161378).